C

    Clover Health Investments Corp (CLOV)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NASDAQ

    $4.15
    -0.08 (-1.89%)

    Market Cap: $2.25B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    71%(17/24)
    Avg Surprise
    -10.69%
    Streak
    3 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.01
    Range$0.01 - $0.01
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.00-100.0%
    60d ago$0.00-100.0%
    30d ago$0.00-100.0%
    7d ago$0.00-100.0%
    Current$0.01
    Revenue Consensus
    $738M
    Range$728M - $744M
    3 analysts
    Dec 31, 2026
    EPS Consensus$0.01
    Range$0.01 - $0.01
    1 analysts
    Revenue Consensus
    $773M
    Range$757M - $783M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.01---
    Sep 26EST
    		-$0.01---
    Jun 26
    		$0.06$0.05+20.00%Beat+100.0%
    Mar 26
    		$0.07$0.07+0.00%Beat+40.0%
    Dec 25
    		$-0.10$-0.11+9.09%Beat-100.0%
    Sep 25
    		$-0.05$0.02-350.00%Miss-150.0%
    Jun 25
    		$0.03$0.03+0.00%Beat+50.0%
    Mar 25
    		$0.05$-0.07+171.43%Beat+200.0%
    Dec 24
    		$-0.05$-0.07+23.08%Beat+64.3%
    Sep 24
    		$-0.02$-0.03+33.33%Beat+75.0%
    Jun 24
    		$0.02$-0.04+150.00%Beat+140.0%
    Mar 24
    		$-0.05$-0.08+37.50%Beat+64.3%
    Dec 23
    		$-0.14$-0.14+0.00%Beat+17.6%
    Sep 23
    		$-0.08$-0.11+27.27%Beat+50.0%
    Jun 23
    		$-0.05N/A+61.54%Beat+77.3%
    Mar 23
    		$-0.14$-0.17+17.65%Beat+12.5%
    Dec 22
    		$-0.17$-0.26+34.62%Beat+39.3%
    Sep 22
    		$-0.16$-0.24+33.33%Beat-100.0%
    Jun 22
    		$-0.22$-0.20-10.00%Miss+71.8%
    Mar 22
    		$-0.16$-0.27+40.74%Beat-23.1%
    Dec 21
    		$-0.28$-0.26-7.69%Miss+85.3%
    Sep 21
    		$-0.08N/A+65.22%Beat-126.8%
    Jun 21
    		$-0.78$-0.14-457.14%Miss-362.8%
    Mar 21
    		$-0.13$-0.10-30.00%Miss+51.1%
    Dec 20
    		$-1.90$-0.84-126.19%Miss-614.3%
    Sep 20
    		$0.30$0.30-0.37%Miss+124.8%
    Jun 20
    		$0.30N/AN/ABeat+110.8%
    Mar 20
    		$-0.27$0.00N/AMiss+90.4%
    Dec 19
    		$-0.27$0.00N/AMiss-
    Jun 19
    		$-1.21$0.00N/AMiss-
    Mar 19
    		$-2.76$0.00N/AMiss-
    Dec 18
    		$-2.76$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-207.50EV/EBITDA-0.65x
    Price/FCF29.31xFCF Yield3.41%
    Profitability
    Profit Margin-0.74%Operating Margin3.77%
    ROE-5.10%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    Beta2.48Avg Volume4.34M
    52-Week High$5.5952-Week Low$1.58

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.18
    SMA 20$4.32
    SMA 50$4.58
    SMA 200$3.10
    EMA 10$4.22
    EMA 20$4.29
    EMA 50$4.30
    EMA 200$3.55

    MACD

    Line: -0.09Signal: -0.08Hist: -0.01

    ADX

    ADX: 13.6+DI: 18.5-DI: 21.8

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down84.0
    PSAR$4.64

    Bollinger Bands

    Upper Band$4.73
    Lower Band$3.92
    %B Position1892%(Upper)
    Band Width0.29

    RSI (14-Day)

    Neutral
    43.6

    Momentum Oscillators

    Stoch %K25.8
    Stoch %D24.3
    Williams %R-80.8
    ROC (10d)-2.8%
    Momentum-0.12
    CCI (20d)-63.4
    MFI (14d)37.8

    Volatility Measures

    ATR (14d)$0.21(5.0%)
    StdDev (20d)0.20
    Hist Vol63.0%(High)

    Volume Flow

    VWAP$4.18
    OBV-127.1M
    AD Line-112.0M
    CMF (20d)-0.311

    Volume Metrics

    Avg Vol (20d)4.4M
    Vol Ratio0.8x
    VWMA (20d)$4.39

    Pivot Points

    R3$4.41
    R2$4.35
    R1$4.29
    Pivot Point$4.23
    S1$4.17
    S2$4.11
    S3$4.05

    Advanced Oscillators

    TSI-9.73
    Ultimate Osc43.4
    KST-75.72

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$743.17M$749.19M$487.71M$496.65M$477.62M$462.33M$336.50M$330.99M$356.26M$346.92M$307.66M$306.03M
    Cost of RevenueN/A$589.65M$413.50M$423.47M$377.99M$353.44M$243.04M$249.77M$248.35M$265.16M$447.99M$235.78M
    Gross ProfitN/A$159.54M$74.21M$73.18M$99.63M$108.89M$93.92M$81.21M$107.91M$81.76M$62.27M$70.24M
    Operating Expenses$715.17M$721.86M$537.03M$521.03M$488.18M$463.61M$358.41M$339.77M$349.07M$369.63M$375.52M$339.64M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$0$0$0$0$0$0$0$0$0$0$0$0
    Operating IncomeN/A$27.33M$-49,319,000$-24,377,000$-10,559,000$-1,274,000$-21,448,000$-8,785,000$7.19M$-22,703,000$-65,660,000$-33,616,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$1,000$0$0$0$0$0$0$0$0$0
    Income Before Tax$28.00M$27.33M$-49,319,000$-24,377,000$-10,559,000$-1,274,000$-21,915,000$-8,785,000$7.19M$-22,703,000$-67,859,000$-33,616,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$28.00M$27.33M$-49,320,000$-24,377,000$-10,578,000$-1,274,000$-22,092,000$-9,155,000$7.41M$-19,170,000$-70,472,000$-41,469,000
    EBITDA$28.14M$27.41M$-49,399,000$-24,367,000$-10,674,000$-1,245,000$-21,922,000$-8,968,000$6.57M$-23,056,000$-68,017,000$-34,302,000
    EBIT$28.00M$27.33M$-49,319,000$-24,377,000$-10,559,000$-1,274,000$-21,915,000$-8,785,000$7.19M$-22,703,000$-67,859,000$-33,616,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CLOV

    News

    Clover Health interim CFO Thornton sells $78,032 in shares By Investing.com

    Joseph Clay Thornton, interim CFO of Clover Health Investments Corp., sold 17,775 shares valued at $78,032. These sales were not discretionary but were "sell to cover" transactions to meet tax withholding obligations from vesting restricted stock units (RSUs). The company has recently reported strong Q2 2026 financial results, exceeding Wall Street expectations, and raised its full-year outlook.

    Investing.com Canada•8/18/26•
    Neutral

    Clover Health interim CFO Thornton sells $78,032 in shares

    Joseph Clay Thornton, interim CFO of Clover Health Investments, sold 17,775 shares of the company's Class A Common Stock for $78,032. These sales were not discretionary but rather "sell to cover" transactions to meet tax withholding obligations from vesting restricted stock units (RSUs). Following the transactions, Thornton beneficially owns 1,249,526 shares.

    Investing.com•8/17/26•
    Somewhat-Bullish

    Clover Health (NASDAQ: CLOV) CFO’s tax sale covers RSU vesting

    Clover Health's Interim CFO, Joseph Clay, sold 17,775 shares of Class A Common Stock at a weighted average price of $4.39 per share on August 17, 2026. This transaction was a non-discretionary "sell to cover" to satisfy tax obligations related to the vesting of 6.25% of his restricted stock units (RSUs). After the sale, Clay directly holds 1,249,526 shares, and his remaining RSUs will continue to vest quarterly through February 2028.

    Stock Titan•8/17/26•
    Neutral

    Clover Health (NASDAQ: CLOV) notes $21K 10b5-1 sale by Thornton

    Clover Health Investments Corp. (NASDAQ: CLOV) filed a Form 144, indicating a planned transaction involving 16,942 Class A shares linked to restricted stock units granted on August 16, 2026. The filing also disclosed a prior 10b5-1 Plan Sale by Joseph Clay Thornton on July 15, 2026, where 4,630 Class A shares were sold for $21,622.10. The shares for the planned transaction are held through Morgan Stanley Smith Barney LLC.

    Stock Titan•8/17/26•
    Neutral

    Clover Health Interim CFO Joseph Clay Thornton Awarded 54,347 RSUs with Four-Year Vesting

    Clover Health's Interim CFO, Joseph Clay Thornton, was granted 54,347 Restricted Stock Units (RSUs) of Class A Common Stock. These RSUs, valued at $0, will vest over a four-year period, with 25% vesting on August 12, 2027, and the remainder in quarterly installments, fully vesting by August 12, 2030. This grant increases Thornton's direct beneficial ownership to 1,267,301 shares of Class A Common Stock, contingent upon his continued service.

    Kalkine Media•8/14/26•
    Neutral

    Frequently Asked Questions About CLOV

    Does CLOV pay dividends?
    Clover Health Investments Corp (CLOV) does not currently pay a regular dividend.
    What is CLOV's market cap?
    Clover Health Investments Corp (CLOV) has a market capitalization of $2.25B with a current stock price of $4.15.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In